Logo image of NARI

INARI MEDICAL INC (NARI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NARI - US45332Y1091 - Common Stock

79.97 USD
+0.04 (+0.05%)
Last: 2/18/2025, 8:00:58 PM
79.98 USD
+0.01 (+0.01%)
After Hours: 2/18/2025, 8:00:58 PM
Fundamental Rating

4

Overall NARI gets a fundamental rating of 4 out of 10. We evaluated NARI against 184 industry peers in the Health Care Equipment & Supplies industry. NARI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NARI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • NARI had negative earnings in the past year.
  • NARI had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NARI reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: NARI reported negative operating cash flow in multiple years.
NARI Yearly Net Income VS EBIT VS OCF VS FCFNARI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

  • NARI has a Return On Assets (-11.27%) which is comparable to the rest of the industry.
  • NARI's Return On Equity of -18.07% is fine compared to the rest of the industry. NARI outperforms 60.96% of its industry peers.
Industry RankSector Rank
ROA -11.27%
ROE -18.07%
ROIC N/A
ROA(3y)-0.97%
ROA(5y)0.17%
ROE(3y)-1.09%
ROE(5y)-0.88%
ROIC(3y)N/A
ROIC(5y)N/A
NARI Yearly ROA, ROE, ROICNARI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

  • NARI's Gross Margin of 86.82% is amongst the best of the industry. NARI outperforms 97.33% of its industry peers.
  • NARI's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NARI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5Y1.71%
NARI Yearly Profit, Operating, Gross MarginsNARI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50 -100

6

2. Health

2.1 Basic Checks

  • NARI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NARI has been increased compared to 1 year ago.
  • There is no outstanding debt for NARI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NARI Yearly Shares OutstandingNARI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
NARI Yearly Total Debt VS Total AssetsNARI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

  • NARI has an Altman-Z score of 11.25. This indicates that NARI is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.25, NARI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • There is no outstanding debt for NARI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.25
ROIC/WACCN/A
WACC8.93%
NARI Yearly LT Debt VS Equity VS FCFNARI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

  • NARI has a Current Ratio of 1.77. This is a normal value and indicates that NARI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.77, NARI is not doing good in the industry: 71.12% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.40 indicates that NARI should not have too much problems paying its short term obligations.
  • NARI has a worse Quick ratio (1.40) than 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.4
NARI Yearly Current Assets VS Current LiabilitesNARI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

6

3. Growth

3.1 Past

  • The earnings per share for NARI have decreased strongly by -1183.33% in the last year.
  • Looking at the last year, NARI shows a very strong growth in Revenue. The Revenue has grown by 22.39%.
  • The Revenue has been growing by 135.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-280%
Revenue 1Y (TTM)22.39%
Revenue growth 3Y52.31%
Revenue growth 5Y135.6%
Sales Q2Q%21.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 121.24% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 17.44% on average over the next years. This is quite good.
EPS Next Y-2492.94%
EPS Next 2Y192.8%
EPS Next 3Y191.18%
EPS Next 5Y121.24%
Revenue Next Year22.24%
Revenue Next 2Y20.1%
Revenue Next 3Y18.92%
Revenue Next 5Y17.44%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NARI Yearly Revenue VS EstimatesNARI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
NARI Yearly EPS VS EstimatesNARI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NARI. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 405.53, the valuation of NARI can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NARI indicates a somewhat cheap valuation: NARI is cheaper than 64.71% of the companies listed in the same industry.
  • NARI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.83.
Industry RankSector Rank
PE N/A
Fwd PE 405.53
NARI Price Earnings VS Forward Price EarningsNARI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300 400

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, NARI is valued a bit cheaper than the industry average as 66.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2971.47
EV/EBITDA N/A
NARI Per share dataNARI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • NARI's earnings are expected to grow with 191.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y192.8%
EPS Next 3Y191.18%

0

5. Dividend

5.1 Amount

  • NARI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INARI MEDICAL INC / NARI FAQ

What is the fundamental rating for NARI stock?

ChartMill assigns a fundamental rating of 4 / 10 to NARI.


What is the valuation status for NARI stock?

ChartMill assigns a valuation rating of 2 / 10 to INARI MEDICAL INC (NARI). This can be considered as Overvalued.


What is the profitability of NARI stock?

INARI MEDICAL INC (NARI) has a profitability rating of 3 / 10.